Recent MSK Discoveries & Advances

Recent MSK Discoveries & Advances

Share
Share

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
377 News Items found
Ask the Expert
Five people on the beach during a sunset
Does Vitamin D Reduce the Risk of Getting Cancer?
Two MSK medical oncologists discuss the link between the "sunshine vitamin" and cancer.
Announcement
Hematologic oncologist Martin Tallman and nurse practitioner Bernadette Cuello
FDA Approves Ivosidenib (Tibsovo®), a Targeted Drug, for Acute Myeloid Leukemia
The drug provides a new treatment option for people whose cancer has stopped responding to other therapies.
In the Lab
This image shows cancer cells (white) and pericytes (green) clinging to capillaries (red). The blue dots are nuclei.
Scientists Identify Growth Signal for Metastatic Cancer "Seeds"
Targeting this signal with drugs might be one way to stop cancers from spreading.
Feature
MSK cell manufacturing specialist Xiuyan Wang
Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy
An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.
Finding
CT scans of brains
Research Advances the Genetic Understanding of Pineoblastoma, a Rare Brain Cancer
The findings will lead to more accurate diagnoses and, potentially, to better treatments.
Finding
MSK computational biologist Barry Taylor
Double Jeopardy: Gene-Sequencing Test Uncovers New Clues about a Defect Seen in Many Tumors
MSK researchers have found that a genetic state in tumors called whole-genome doubling is connected with worse outcomes for people with cancer.
In the Lab
MSK physician-scientist Omar Abdel-Wahab
Splicing May Be an Effective Target in the Fight against Cancer
New drugs are being developed that target part of the process to make proteins.
Feature
Side-by-side images of brain MRIs.
New Imaging Technique Provides Snapshot of Brain Tumor Activity
A new imaging approach could shorten the time needed to determine whether a brain tumor treatment is working.
Feature
NK cells attacking
Meet the Unsung Immune Cell that Could Change Immunotherapy
A lesser-known immune cell is suddenly getting more attention in the field of cancer immunology.
In the Clinic
Pink, blue, green, and white blob on black background
Study Shows Liquid Biopsy Is Accurate for Guiding Prostate Cancer Treatment Choice
Detecting a protein in a blood sample could help doctors make treatment decisions for prostate cancer patients.